alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                    Exhibit 99.6

                            Harken Energy Corporation

                          Nominee Holder Certification

     The undersigned, a bank, broker, trustee, depositary or other nominee of
rights (the "Rights") to purchase shares of common stock ("Common Stock") of
Harken Energy Corporation (the "Company") pursuant to the Rights Offering
described and provided for in the Company's prospectus dated            , 2003,
                                                             -----------
(the "Prospectus"), hereby certifies to the Company and to American Stock
Transfer & Trust Company, as Subscription Agent for such rights offering, that
(1) the undersigned has exercised, on behalf of the beneficial owners thereof
(which may include the undersigned), the number of Rights specified below
pursuant to the subscription right (as described in the Prospectus) on behalf of
beneficial owners of Rights (without identifying any such beneficial owner), and
(2) each such beneficial owner's subscription right has been exercised in full:

   Number of Shares Owned (or Issuable
upon Conversion of Preferred Stock Owned)        Rights Exercised Pursuant
           on the Record Date                       to Rights Offering
-----------------------------------------   ------------------------------------

1.
   --------------------------------------   ------------------------------------

2.
   --------------------------------------   ------------------------------------

3.
   --------------------------------------   ------------------------------------

4.
   --------------------------------------   ------------------------------------

5.
   --------------------------------------   ------------------------------------

6.
   --------------------------------------   ------------------------------------

7.
   --------------------------------------   ------------------------------------

8.
   --------------------------------------   ------------------------------------

Provide the following information if applicable:


------------------------------------------------
Depository Trust Company ("DTC")

[PARTICIPANT]


By:
    --------------------------------------------
    Name:
    Title:


------------------------------------------------
DTC Subscription Confirmation Number(s)

                                        1
**Exhibit 32**

**Certification ofChief Executive OfficerPursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of2002, the undersigned officer of Alliance Imaging, Inc. (the “*Company*”) hereby certifies, to such officer’s knowledge,that:

(i)             the accompanying QuarterlyReport on Form 10-Q of the Company for the quarter ended March 31,2006 (the “*Report*”) fully complies with therequirements of Section 13(a) or Section 15(d), as applicable,of the Securities Exchange Act of 1934, as amended; and

(ii)         theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

| Dated:  May 10, 2006 | /s/ PAUL S.  VIVIANO                                |
|---------------------------|-----------------------------------------------------|
|                      | Paul S. Viviano                                     |
|                      | *Chairman of the Board and Chief Executive Officer* |

 

----

**Certification ofChief Financial OfficerPursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of2002, the undersigned officer of Alliance Imaging, Inc. (the “*Company*”) hereby certifies, to such officer’s knowledge,that:

(i)             the accompanying QuarterlyReport on Form 10-Q of the Company for the quarter ended March 31,2006 (the “*Report*”) fully complies with therequirements of Section 13(a) or Section 15(d), as applicable,of the Securities Exchange Act of 1934, as amended; and

(ii)         theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

| Dated: May 10, 2006 | /s/ HOWARD K.  AIHARA                                   |
|--------------------------|---------------------------------------------------------|
|                     | Howard K. Aihara                                        |
|                     | *Executive Vice President and Chief Financial  Officer* |

 

----
<TABLE> <S> <C>

<ARTICLE> 5 

                                                                    EX-27.1

                          FINANCIAL DATA SCHEDULE

<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
ACCOMPANYING FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

       

<S>                               <C>
<PERIOD-TYPE>                           9-MOS     
<FISCAL-YEAR-END>                 DEC-31-1997     
<PERIOD-START>                    JUL-01-1997     
<PERIOD-END>                      SEP-30-1997     
<CASH>                              3,647,000     
<SECURITIES>                       75,838,000     
<RECEIVABLES>                      10,321,000     
<ALLOWANCES>                                0     
<INVENTORY>                                 0     
<CURRENT-ASSETS>                   98,690,000     
<PP&E>                             37,675,000     
<DEPRECIATION>                              0     
<TOTAL-ASSETS>                    382,627,000     
<CURRENT-LIABILITIES>              45,892,000     
<BONDS>                                     0     
<PREFERRED-MANDATORY>                       0     
<PREFERRED>                             1,000     
<COMMON>                               20,000     
<OTHER-SE>                        178,122,000     
<TOTAL-LIABILITY-AND-EQUITY>      382,627,000     
<SALES>                                     0     
<TOTAL-REVENUES>                  181,379,000     
<CGS>                                       0     
<TOTAL-COSTS>                     135,794,000     
<OTHER-EXPENSES>                    8,162,000     
<LOSS-PROVISION>                            0     
<INTEREST-EXPENSE>                  8,957,000     
<INCOME-PRETAX>                    17,347,000     
<INCOME-TAX>                        8,172,000     
<INCOME-CONTINUING>                 9,176,000     
<DISCONTINUED>                              0     
<EXTRAORDINARY>                             0     
<CHANGES>                                   0     
<NET-INCOME>                        9,176,000     
<EPS-PRIMARY>                             .44     
<EPS-DILUTED>                             .47     

        


</TABLE>
<PAGE>


EXHIBIT 32.2

     CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned hereby certifies that, to his knowledge, (i) the Form 10-QSB
filed by Pacicnet Inc. (the "Issuer") for the quarter ended June 30, 2003, fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and (ii) the information contained in that report fairly
presents, in all material respects, the financial condition and results of
operations of the Issuer on the dates and for the periods presented therein.

                                                 PACIFICNET INC.

Date:  August 5, 2003                     By: /s/ Wang Shao Jian
                                              ----------------------------------
                                              Wang Shao Jian
                                              Principal Financial Officer
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                             APR-30-1997
<PERIOD-START>                                MAY-01-1996
<PERIOD-END>                                  OCT-31-1996
<CASH>                                            447,104
<SECURITIES>                                            0
<RECEIVABLES>                                   2,777,597
<ALLOWANCES>                                      137,000
<INVENTORY>                                       265,065
<CURRENT-ASSETS>                                3,761,369
<PP&E>                                          3,262,552
<DEPRECIATION>                                          0
<TOTAL-ASSETS>                                  7,515,648
<CURRENT-LIABILITIES>                           2,103,927
<BONDS>                                           469,347
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                              910
<OTHER-SE>                                      4,941,464
<TOTAL-LIABILITY-AND-EQUITY>                    7,515,648
<SALES>                                         8,251,542
<TOTAL-REVENUES>                                8,251,542
<CGS>                                           5,562,768
<TOTAL-COSTS>                                   9,362,446
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                 29,131
<INCOME-PRETAX>                                  (915,194)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                              (915,194)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                     (915,194)
<EPS-PRIMARY>                                        (.11)
<EPS-DILUTED>                                        (.11)
        

</TABLE>
No. 11-10390.

#### Anderson *v.*United States.

C. A. 5th Cir. Certiorari denied.
<PAGE>

                    [LETTERHEAD OF VINSON & ELKINS L.L.P.]

                                                                     EXHIBIT 8.1

April 1, 2002

US Unwired Inc.
901 Lakeshore Drive
Lake Charles, LA 70601


Ladies and Gentlemen:

     We have acted as counsel for US Unwired Inc., a Louisiana corporation (the
"Company"), in connection with the filing of the registration statement on Form
S-3 with the Securities and Exchange Commission on or about the date hereof
relating to 160,000 Warrants to Purchase Common Stock and 2,074,241 Shares of
Common Stock Issuable Upon Exercise of Warrants (the "Registration Statement").
We have reviewed the description set forth in the Registration Statement under
the caption "Certain United States Federal Income Tax Considerations" and have
concluded that the statements of legal conclusions set forth in that description
constitute our opinion.

     Our opinion is based upon the existing provisions of the Internal Revenue
Code of 1986, as amended, regulations (and administrative pronouncements)
promulgated or proposed thereunder, and interpretations thereof by the Internal
Revenue Service and the courts, all as of the date hereof, all of which are
subject to change with prospective or retroactive effect, and our opinion could
be adversely affected or rendered obsolete by such change.

     We hereby consent to the use of our name in the Registration Statement and
the filing of this opinion with the Securities and Exchange Commission as an
exhibit to the Registration Statement. In giving such consents, we do not admit
that we are in the category of persons whose consent is required under Section 7
of the Securities Act of 1933, as amended, or the rules and regulations
promulgated thereunder.


                                              Very truly yours,


                                              /s/ Vinson & Elkins L.L.P.
Exhibit 10.3.1


 

		
         

         

         

        



 


 


February 25, 2014


 


 


 


Sam Riccitelli

President & CEO

Myeloma Health, LLC

667 Madison Avenue, 14th Floor

New York, NY 10065


 


Dear Mr. Riccitelli,


 


In accordance with Article 5.1(e), Reimbursement of Patent Prosecution
costs, of the License agreement, dated April 01,2010, between Myeloma Health, LLC and the Board of Trustees of the University of
Arkansas (“University”), Myeloma Health, LLC shall reimburse the University for (i) one hundred percent (100%) of the
gene expression profiling only patent costs, (ii) fifty percent (50%) of combination of gene expression profiling and fluorescence
in situ hybridization (FISH) patent costs, and (iii) zero percent (0%) of the fluorescence in situ hybridization (FISH)-only patent
costs incurred by University and paid to third parties in connection with the preparation, filing, prosecution and maintenance
of patent applications and patents.


 


The purpose of this letter is to warrant and certify (i) the
total amount of such out-of-pocket costs incurred by University prior to the Effective date; and, (ii) detail the amount owed by
Myeloma Health, LLC to the University in accordance with the provisions of paragraph one above.


 


As of invoices received from third parties by the University
on March 29, 2010, for the patent applications listed in Appendix A (attached hereto) of the License Agreement, dated April 01,
2010, between Myeloma Health, LLC and the Board of Trustees of the University of Arkansas:


 


(i)Total Patent Costs: $388,654.09

(ii)Myeloma Health: $331,422.59


a.$120,179.00 — 102-08 Patent
Family
 b.$ 48,576.00 — 104-12 Patent Family
 c.$ 68,434.50 — 107-00 Patent Family &
IpEngines’ Analysis
 d.$ 94,233.09 — Additional Patent Rights desired by Myeloma Health, LLC


 






    	 



    	 



    

 


 

Page 2

 

 


As of August 30, 2010, additional patent filings and invoices
on existing patent filings which are included in the first amendment to the License Agreement, dated September 1, 2010, between
Myeloma Health, LLC and the Board of Trustees of the University of Arkansas are as follows:


 


(iii)Total Patent Costs: $25,755

(iv)Myeloma Health: $23,293


a.$10,037 — 109-08 Patent Family

b.$ 2,462 — 109-29 Patent Family

c.$ 1,116 — 110-07 Patent Family

d.$ 3,485 — 110-14 Patent Family

e.$ 1,371 — 110-19 Patent Family

f.$ 4,822 — 111-01 Patent Family


 


Invoicing and reimbursements of the patent costs incurred by
University after the Effective Dates shall be accomplished in accordance with Article 5.1(e) (iii) of the License Agreement, and
Amendment thereto.


 


Warrant and Certify by:


 


/s/ Marie Chow, Ph.D.


 


Marie Chow, Ph.D.


 


Interim Director, UAMS BioVentures
<PAGE>


                                                                    Exhibit 99.1

         CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Lufkin Industries, Inc. (the
"Company") on Form 10-Q for the period ending June 30, 2002, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I Douglas
V. Smith, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
(S)1350, as adopted pursuant to (S)906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.

/s/   Douglas V. Smith
----------------------------
Douglas V. Smith
Chief Executive Officer

August 9, 2002

This certification is made solely for the purpose of 18 U.S.C. (S)1350, and not
for any other purpose.
##### 



EXHIBIT 32.1 Certification of
Chief Executive Officer & Chief Financial Officer
of VCA Antech, Inc. This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and
accompanies this quarterly report on Form 10-Q (the Report) for the period ended March 31, 2005
of VCA Antech, Inc. (the Issuer). Each of the undersigned, who are the Chief Executive Officer and Chief Financial Officer,
respectively, of VCA Antech, Inc., hereby certify that, to the best of each such officers
knowledge:  (i)
    the Report fully complies with the requirements of section 13(a) or section
15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and(ii)
    the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Issuer. Dated: May 6, 2005 /s/ Robert L. AntinRobert L. AntinChief Executive Officer/s/ Tomas W. FullerTomas W. FullerChief Financial Officer 48
#### Jaamal FLEMING, Plaintiff-Appellant, v. VIRGINIA STATE UNIVERSITY; Policies and Petitions Committee; Academic Credit Committee; Katrina Walker; Commonwealth of Virginia, Defendants-Appellees.

No. 17-1814

United States Court of Appeals, Fourth Circuit.

Submitted: December 29, 2017

Decided: March 5, 2018

*230Jaamal Fleming, Appellant Pro Se. Ramona Leigh Taylor, VIRGINIA STATE UNIVERSITY, Petersburg, Virginia, for Appellees.

Before NIEMEYER and HARRIS, Circuit Judges, and SHEDD, Senior Circuit Judge.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Jaamal Fleming appeals from the district court’s order dismissing his civil action for breach of contract, defamation, and fraud for lack of subject matter jurisdiction based on Eleventh Amendment immunity. Appellees argue that the action is barred by the doctrine' of res judicata. Assuming without deciding that the doctrine of res judicata does not bar Fleming’s complaint, we conclude after review of the record that the district court did not reversibly err in determining that it lacked subject matter jurisdiction over the complaint. We therefore affirm the district court’s dismissal decision. *Fleming v. Va. State Univ.,*No. 3:17-cv-00411-JAG, 2017 WL 4484262 (E.D. Va. June 9, 2017). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

*AFFIRMED*
No. 11-9344.

#### El Falesteny *v.*Obama, President of the United States, et al.

C. A. D. C. Cir. Motion of respondents for leave to file a brief in opposition under seal granted. Motion of petitioner for leave to file a reply brief under seal granted. Certiorari denied.
Exhibit 32.1
                                                                   ------------

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report on Form 10-Q of Golden River Resources
Corporation (the "Company") for the six months ended December 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the "report"),
the undersigned, Joseph Gutnick, Chief Executive Officer of the Company,
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 that:

(1)      The report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

(2)      The information contained in the report fairly presents, in all
         material respects, the financial condition and result of operations of
         the Company.


Date:    13 February, 2009

                                            /s/ Joseph I. Gutnick
                                            ------------------------------------
                                            Joseph I. Gutnick
                                            Chairman of the Board, President and
                                            Chief Executive Officer

                                                                             25
| (logo) ncb

National Cooperative Bank | 2011 Crystal Drive

Suite 800

Arlington, VA 22202 |
|---------------------------------------|----------------------------------------------------|

 

 

February 26, 2016

 

Wells Fargo Commercial Mortgage Securities, Inc. as Depositor

Attn: AJ Sfarra

375 Park Avenue, 2nd Floor

J0127-023

New York, NY 10152

 

RE: Annual Statement as to Compliance WFCM 2014 LC18

 

Dear Sir/Madam:

 

In accordance with the Pooling and Servicing Agreement entered into in connection with the issuance of the Commercial Mortgage Pass-Through Certificates Series 2014-LC18, as an authorized officer of National Cooperative Bank, N.A., formerly NCB, FSB (the “NCB Master Servicer”), I hereby certify pursuant to Section 11.12 thereof that:

 

a. A review of the activities of the NCB Master Servicer during the preceding calendar year (the “Reporting Period”) and of its performance under the Pooling and Servicing Agreement has been made under my supervision.

 

b. To the best of my knowledge, based on these reviews, the NCB Master Servicer has fulfilled all obligations under this agreement in all material respects throughout the Reporting Period.

 

Please note that the annual financial statement will be sent under separate cover on or before March 31, 2016.

 

 

Best regards,

 

/s/ Karyn Mann

Karyn Mann

Senior Vice President, Investor Compliance 

National Cooperative Bank, N.A.